Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

718 indexed citations
published 1998

Countries where authors are citing Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

Specialization
Citations

This map shows the geographic impact of Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. more than expected).

Fields of papers citing Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas..

About Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

This paper, published in 1998, received 718 indexed citations . Written by Toyoaki Hida, Yasushi Yatabe, Hiroyuki Achiwa, Hideki Muramatsu, Shigeo Nakamura, Makoto Ogawa, Tetsuya Mitsudomi, Takahiko Sugiura and Takashi Takahashi covering the research area of Genetics and Pharmacology. It is primarily cited by scholars working on Pharmacology (510 citations), Genetics (290 citations) and Molecular Biology (187 citations). Published in PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/w27747885.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026